Entangled Conditional Adversarial Autoencoder for de Novo Drug Discovery

Polykovskiy, Daniil, Zhebrak, Alexander, Vetrov, Dmitry, Ivanenkov, Yan, Aladinskiy, Vladimir, Mamoshina, Polina, Bozdaganyan, Marine, Aliper, Alexander, Zhavoronkov, Alex, Kadurin, Artur·2018·Molecular Pharmaceutics
DOI 10.1021/acs.molpharmaceut.8b00839

Cited by (279)

Items 201–279 of 279

  1. Review of Disentanglement Approaches for Medical Applications: Towards Solving the Gordian Knot of Generative Models in Healthcare
    Fragemann, Jana, Ardizzone, Lynton, Egger, Jan, Kleesiek, Jens, Workshop, Mad · 2022
  2. Generative Molecular Design and Experimental Validation of Selective Histamine H1 Inhibitors
    Kevin McLoughlin, Da Shi, Jeffrey E. Mast, John Bucci, John P. Williams, WILLIAM D Jones, Derrick Miyao, Luke Nam, Heather L. Osswald, L. A. Zegel'man et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  3. Exploring the macrocyclic chemical space for heuristic drug design with deep learning models
    Feng Hu, Xiaotong Jia, Wenjie Liao, Ziqi Chen, Hongjie Bi, Huan Ge, Dandan Liu, Rongrong Zhang, Yongtong Hu, Wenyi Mei et al. · 2025 · Communications Chemistry
  4. The Emerging Role of Artificial Intelligence in Drug Discovery and Development: Implications for Cardiovascular Pharmacology
    Alaa Abdelhamid, Dima Nasrallah, Yaman Al-Haneedi, Esraa A. Ahmed, Ali Hussein Eid · 2026 · Journal of Cardiovascular Pharmacology
  5. A Reinforcement Learning-Guided Genetic Algorithm Integrating Medicinal Chemistry-Inspired Molecular Transformations
    Domenico Alberga, Vittoria Nanna, Maria Giovanna, Eva Papadopoulos, Adolfo Ancona, Maria Cristina Lomuscio, Giuseppe Felice Mangiatordi · 2026 · Journal of Chemical Information and Modeling
  6. Deep generative models in the quest for anticancer drugs: ways forward
    Virgilio Romanelli, Carmen Cerchia, Antonio Lavecchia · 2024 · Frontiers in Drug Discovery
  7. Revolutionizing Drug Discovery: A Systematic Review of AI and Machine Learning Application
    Ismatul Jannat Chowdhury, Md. Shorif Hossan, Mohammed Ziauddin Khan, Tanvir Zobair Mahboob, Yadab Sutradhar, Md. Anwar Hossain, Md Masum · 2025 · International Conference on Self Sustainable Artificial Intelligence Systems (ICSSAS)
  8. Transforming modern drug discovery with machine learning – applications in ligand-based drug design
    Souvik Pore, Kunal Roy · 2025 · Annual reports in medicinal chemistry
  9. AnoChem: Prediction of chemical structural abnormalities based on machine learning models
    Changdai Gu, Woo Dae Jang, Kwang-Seok Oh, Jae Yong Ryu · 2024 · Computational and Structural Biotechnology Journal
  10. Artificial intelligence in drug discovery: Current applications and future directions
    Ahmad Asri Awad Alanazi, ‏Abdulrahman Ibrahim Abdullah Al Fahad, Abdullah Saleh Abdullah Almorshed, Abdullah Abdulrahman Mohammed Alrbian, Ahmed Abdulkarim Sulaiman Alnughaymishi, Nawal Haif Bajad Al-Mutairi, Abdulrahman Amer Alajmi, Sanytan Ghazy Al Otaibi · 2022 · International Journal of Health Sciences
  11. MGDM: Molecular generation using a multinomial diffusion model
    Sisi Yuan, Chen Zhao, Lin Liu, Guifei Zhou · 2025 · Methods
  12. A “sweeter” approach to cancer immunotherapy: Glycopolymers as diverse tools for immune modulation
    Kenneth Hulugalla, Oluwatosin David Abodunrin, Joshua Anderson, Adam E. Smith, Thomas A. Werfel · 2025 · Journal of Controlled Release
  13. Target discovery and drug design in the era of artificial intelligence
    Payton Fleming, Andrey A. Ivanov · 2026 · Medicinal Chemistry Research
  14. A disentangled generative model for improved drug response prediction in patients via sample synthesis
    Kunshi Li, Bihan Shen, Fangyoumin Feng, Xueliang Li, Yue Wang, Na Feng, Zhixuan Tang, Liangxiao Ma, Hong Li · 2024 · Journal of Pharmaceutical Analysis
  15. Chemoinformatic approaches for navigating large chemical spaces
    Martin Vogt · 2024 · Expert Opinion on Drug Discovery
  16. Unlocking precision medicine: Innovative strategies for druggable target identification and therapeutic enhancement
    Yang Liao, Zhangle Wei, Hangwei Xu, Zhichao Zhang, Feng Zhu · 2024 · Precision medication.
  17. REVOLUTIONIZING DRUG DEVELOPMENT: HOW AI AND MACHINE LEARNING ARE SHAPING THE FUTURE OF MEDICINE-A REVIEW
    GIRIDHARA MAHADEVASWAMY, GURUBARAN SIVANATHAN, SANJAI RAJAGOPAL, GOWTHAM ANGAMUTHU, Dhandapani Nagasamy Venkatesh · 2025 · International Journal of Applied Pharmaceutics
  18. Development of a Deep Learning Generative Neural Network for Computer-Aided Design of Potential SARS-Cov-2 Inhibitors
    N.A. Shuldau, Artsemi M. Yushkevich, Konstantin V. Furs, Alexander V. Tuzikov, Alexander M. Andrianov · 2022 · Mathematical Biology and Bioinformatics
  19. Saccharide Concentration Prediction from Proxy Ocean Samples Analyzed Via Infrared Spectroscopy and Quantitative Machine Learning
    Nicole M. North, Abigail A. A. Enders, Jessica B. Clark, Kezia A. Duah, Heather Cecile Allen · 2024 · ACS Earth and Space Chemistry
  20. Deep learning approaches for de novo drug design: an overview
    Mingyang Wang, Dan Li, Tingjun Hou, Yu Kang · 2022 · Scientia Sinica Chimica
  21. Development of Integrated Machine Learning and Data Science Approaches for the Prediction of Cancer Mutation and Autonomous Drug Discovery of Anti-Cancer Therapeutic Agents
    Steve Agajanian · 2021 · Chapman University Digital Commons (Chapman University)
  22. Amortized Synthesis of Constrained Configurations Using a Differentiable Surrogate
    Xingyuan Sun, Tianju Xue, Szymon M. Rusinkiewicz, Ryan Prescott Adams · 2021 · arXiv (Cornell University)
  23. Saccharide concentration prediction from proxy-sea surface microlayer samples analyzed via ATR-FTIR spectroscopy and quantitative machine learning
    Abigail A. A. Enders, Nicole M. North, Jessica B. Clark, Heather Cecile Allen · 2023 · ChemRxiv
  24. Designing new hit series of JAK3 inhibitors using generative AI, reinforcement learning, and molecular dynamics
    Nhung Hong Thi Duong, Tuan Ngoc Do, Lap Thi Nguyen · 2025 · Computers in Biology and Medicine
  25. THE AI REVOLUTION IN PHARMACEUTICALS: INNOVATIONS, CHALLENGES, AND FUTURE PROSPECTS – AN OVERVIEW
    R. VIGNESH, Marakanam Srinivasan Umashankar, Damodharan Narayanasamy · 2026 · International Journal of Applied Pharmaceutics
  26. Defining chemical problems for artificial intelligence models
    Joonyoung F. Joung · 2026 · Bulletin of the Korean Chemical Society
  27. De Novo Drug Design via Multi-Label Learning and Adversarial Autoencoder
    Qing Ye, Xiaolong Zhang, Xiaoli Lin · 2021 · IEEE International Conference on Bioinformatics and Biomedicine (BIBM)
  28. Status and Prospects of Research on Deep Learning-based De Novo Generation of Drug Molecules
    Huanghao Shi, Zhichao Wang, Litao Zhou, Zhiwang Xu, Liangxu Xie, Ren Kong, Shan Chang · 2024 · Current Computer - Aided Drug Design
  29. Drug Molecule Generation Method Based on Fusion of Protein Sequence Features
    Mengyao Wang, Xiaolong Zhang, Haoran Liu, Xiaoli Lin, Jing Hu, Jun Pang · 2024 · Lecture notes in computer science
  30. A generative neural network based on a hetero-encoder model for de novo design of potential anticancer drugs: application to Bcr-Abl tyrosine kinase
    Anna D. Karpenko, T. D. Vaitko, Alexander V. Tuzikov, Alexander M. Andrianov · 2023 · Informatics
  31. Application of transformer model architecture in the new drugs design
    Давронов Рифкат Раxимович, Abdumalikov Shoxrux Qaxramon O'g'li, Safarov Ro'zmat Abdiqayum O'g'li · 2021 · International Conference on Information Science and Communications Technologies (ICISCT)
  32. In Silico and Biophysical Techniques in Anticancer Drug Discovery Research
    Aljabal Ghazi, Beow Keat Yap · 2024 · Interdisciplinary cancer research
  33. The Human Intelligence Versus Artificial Intelligence: A Controversial Race in Problem-Solving
    Kawthar Mohamed, Ahmed Mushtaq, Mujtaba Shaw, Irene Ling, Musa Joya, Sara A. Makka, Rangarirai Makuku, Leander Penaso Marquez, Nima Rezaei · 2024 · Integrated science
  34. ADMETrix: ADMET-Driven De Novo Molecular Generation
    Nikolaos Mourdoukoutas, Aigli Korfiati, Vassilis Pitsikalis · 2025 · Lecture notes in computer science
  35. Long short-term memory-based chemical language models for bioactive molecular generation using tailored pre-training datasets
    Ryuto Abe, Tomoyuki Miyao · 2026 · Artificial Intelligence in the Life Sciences
  36. Rapid Generative Discovery of High‐Energy Molecules in Low Data Regimes Using Minimal Computational Resources
    Siddharth Verma, Alankar Alankar · 2026 · Propellants Explosives Pyrotechnics
  37. Generative Active Learning for Molecular Design with REINVENT: Balancing Binding Affinity and Synthetic Accessibility
    Marco Klähn, Hannes H. Loeffler, Shunzhou Wan, Alexey Voronov, Xibei Zhang, Agastya P. Bhati, Peter V. Coveney · 2026 · Journal of Chemical Theory and Computation
  38. De Novo Drug Design by Multi-Objective Path Consistency Learning With Beam A* Search
    Dengwei Zhao, Jingyuan Zhou, Shikui Tu, Lei Xu · 2024 · IEEE Transactions on Computational Biology and Bioinformatics
  39. Brain-Supervised Conditional Generative Modeling
    Jun Ma, Tuukka Ruotsalo · 2025 · IEEE Transactions on Human-Machine Systems
  40. A Comprehensive Review on Machine Learning and Deep Learning Methods in Drug Discovery
    Sneha Khaire, Pawan Bhaladhare · 2022 · International Journal on Recent and Innovation Trends in Computing and Communication
  41. Discovering Novel Pharmaceutical Molecules with Generative Adversarial Networks
    Leena Chandrashekar, K. Namratha, Padmapriya Mohan, Raxna Bojamma P J, Aditi Kulkarni · 2023 · Proceeding of the Electrical Engineering Computer Science and Informatics
  42. Real-World Applications of Artificial Intelligence and Blockchain in Healthcare
    Aria Naraghi, Reza Nourmohammadi, Iman Behravan · 2023 · SSRN Electronic Journal
  43. Machine learning approaches for drug virtual screening
    Benoît Playe · 2019 · theses.fr (ABES)
  44. Generative Active Learning for Molecular Design with REINVENT: Balancing Binding Affinity and Synthetic Accessibility
    Marco Klähn, Hannes H. Loeffler, Shunzhou Wan, Alexey Voronov, Xibei Zhang, Agastya P. Bhati, Peter V. Coveney · 2026 · ChemRxiv
  45. GenUI: Interactive and Extensible Open Source Software Platform for De Novo Molecular Generation
    Martin Šícho, Xuhan Liu, Daniel Svozil, Gerard J. P. van Westen · 2021 · ChemRxiv
  46. Accelerating Inhibitor Discovery for Multiple SARS-CoV-2 Targets with a Single, Sequence-Guided Deep Generative Framework
    Vijil Chenthamarakshan, Samuel C. Hoffman, Callum D. Owen, Petra Lukacik, Claire M. Strain-Damerell, D. Fearon, Tika R. Malla, Anthony Tumber, Christopher Schofield, Helen M. E. Duyvesteyn et al. · 2022 · Research Square
  47. Applying Disentanglement in the Medical Domain: An Introduction for the MAD Workshop
    Jana Fragemann, Xiao Liu, Jianning Li, Sotirios A. Tsaftaris, Jan Egger, Jens Kleesiek · 2023 · Lecture notes in computer science
  48. Deep learning methodologies in drug design
    Haralambos Sarimveis, Chrysoula Gousiadou, Philip Doganis, Pantelis Karatzas, Iason Sotiropoulos, Periklis Tsiros · 2023 · Elsevier eBooks
  49. Versatile Molecular Editing via Multimodal and Group-optimized Generative Learning
    Xiaohan Lin, Yijie Xia, Yupeng Huang, Shuo Liu, Mengyun Chen, Ningxi Ni, Zidong Wang, Yi Qin Gao, Jun Zhang · 2023 · ChemRxiv
  50. Saccharide concentration prediction from proxy sea surface microlayer samples analyzed via infrared spectroscopy and quantitative machine learning
    Abigail A. A. Enders, Nicole M. North, Jessica B. Clark, Heather Cecile Allen, Kezia A. Duah · 2023 · ChemRxiv
  51. Critical Assessment of Generative Models for de Novo Molecular Structure Generation
    Tomoyuki Miyao · 2023 · Journal of Computer Aided Chemistry
  52. Versatile Molecular Editing via Multimodal and Group-optimized Generative Learning
    Xiaohan Lin, Yijie Xia, Yupeng Huang, Shuo Liu, Jun Zhang, Yi Qin Gao · 2024 · ChemRxiv
  53. Transformer models for protein-guided drug compound generation: A comparison of amino acid sequences, pre-trained protein embeddings, SMILES, and SELFIES
    Dylan Fossl · 2024
  54. Navigating the Promises and Perils of Generative AI in Transforming Healthcare Services
    Sahil Kohli, Ravi Kaushal, Ashish Raina · 2025 · Advances in hospitality, tourism and the services industry (AHTSI) book series
  55. ADMETrix: ADMET-Driven De Novo Molecular Generation
    Nikolaos Mourdoukoutas, Aigli Korfiati, Vasilis Pitsikalis · 2025 · ChemRxiv
  56. ADMETrix: ADMET-Driven De Novo Molecular Generation
    Nikolaos Mourdoukoutas, Aigli Korfiati, Vasilis Pitsikalis · 2025 · ChemRxiv
  57. Intelligent design and synthesis of nucleobase and amino acid-based ligands to inhibit the JAK2 enzyme to treat rheumatoid arthritis
    Ameneh Zarei, Alireza Fattahi · 2025 · Amino Acids
  58. Additional file 1 of CReM: chemically reasonable mutations framework for structure generation
    Павел Геннадьевич Полищук · 2020 · Figshare
  59. Additional file 1 of MolFilterGAN: a progressively augmented generative adversarial network for triaging AI-designed molecules
    Liu, Xiaohong, Zhang, Wei, Tong, Xiaochu, Feisheng Zhong, Li, Zhaojun, Zhaoping Xiong, Jiacheng Xiong, Wu, Xiaolong, Zunyun Fu, Tan, Xiaoqin et al. · 2024 · Figshare
  60. AgainstOTE: A generative pretrain-tune framework for de novo molecular generation against off-target effects
    Yechao Xu, Wen Fang, Shuai Wang, Hai-Bin Luo, Qiang Xu, Fen-Er Chen, Jiao Qu, Yang Sun · 2025 · The Innovation Medicine
  61. Molecule Generation Models
    ShuiGeng ZHOU · 2025 · Springer eBooks
  62. From Latent Manifolds to Targeted Molecular Probes: An Interpretable, Kinome-Scale Generative Machine Learning Framework for Family-Based Kinase Ligand Design
    Gennady M. Verkhivker, Ryan Kassab, Keerthi Krishnan · 2026 · Biomolecules
  63. Network-based machine learning methods to model variability across individuals
    Behnam Yousefi · 2023 · theses.fr (ABES)
  64. Revolutionizing Drug Discovery: The Evolving Role of Artificial Intelligence and Machine Learning
    Harikrishna Bommala · 2026 · International Journal of Creative and Open Research in Engineering and Management
  65. CReM update: a faster, more compact, and more flexible framework for chemically reasonable mutations
    Павел Геннадьевич Полищук · 2026 · ChemRxiv
  66. Machine Learning in Natural Product-based Drug Discovery
    Gargee Mahajan, Neha Kadam, Prashant S. Kharkar · 2026 · Royal Society of Chemistry eBooks
  67. Chemical Language Model Applications in Medicinal Chemistry
    Gauri Mishra, Vaibhav A. Dixit · 2026 · Royal Society of Chemistry eBooks
  68. GANs in Peptide Drug Discovery: From De Novo Design to Multi-Property Optimization and Clinical Translation
    Yanyan Chu, Shanshan Zhang, Bin Pan, Qingbao Zhang, Xin Zhou, Ying Liu, Feng Li · 2026 · Probiotics and Antimicrobial Proteins
  69. From Computational Chemistry to Generative Models: A Survey of AI-Driven Small-Molecule Drug Discovery
    Houman Kazemzadeh, Kiarash Mokhtari, Nazanin Mirzaei, Seyed Reza Tavakoli, Ali Reza Keivanimehr, Shayan Majidifar, Ali Behrad, Farbod Davoodi, Sina Khosravi, Behdad Alikhani et al. · 2026 · ChemRxiv
  70. From Computational Chemistry to Generative Models: A Survey of AI-Driven Small-Molecule Drug Discovery
    Houman Kazemzadeh, Kiarash Mokhtari, Seyed Reza Tavakoli, Nazanin Mirzaei, Ali Reza Keivanimehr, Shayan Majidifar, Ali Behrad, Farbod Davoodi, Sina Khosravi, Behdad Alikhani et al. · 2026 · ChemRxiv
  71. Revolutionizing Pharmaceuticals With AI-Driven Drug Delivery, Design, and Development
    K. Kesavardhini, P. Saranraj, Balachander Lokeshwari, Krishnaswamy Veena Gayathri, K. Arthi · 2026 · Advances in computational intelligence and robotics book series
  72. BindingDB Entry 50010960: Learning Molecular Representations for Medicinal Chemistry.
    BindingDB · 2021 · UC San Diego
  73. BindingDB Entry 50023694: Design, Synthesis, and Biological Evaluation of Novel Orally Available Covalent CDK12/13 Dual Inhibitors for the Treatment of Tumors.
    BindingDB · 2026 · UC San Diego
  74. BindingDB Entry 50020701: Discovery of Potent, Selective, and Orally Bioavailable Small-Molecule Inhibitors of CDK8 for the Treatment of Cancer.
    BindingDB · 2024 · UC San Diego
  75. BindingDB Entry 50023008: Discovery of a Novel Macrocyclic Noncovalent CDK7 Inhibitor for Cancer Therapy.
    BindingDB · 2026 · UC San Diego
  76. BindingDB Entry 50022937: Discovery of Potent, Highly Selective, and Orally Bioavailable MTA Cooperative PRMT5 Inhibitors with Robust In Vivo Antitumor Activity.
    BindingDB · 2026 · UC San Diego
  77. BindingDB Entry 50021522: Discovery of Tetrahydropyrazolopyrazine Derivatives as Potent and Selective MYT1 Inhibitors for the Treatment of Cancer.
    BindingDB · 2025 · UC San Diego
  78. BindingDB Entry 50021620: Discovery of Novel and Potent Prolyl Hydroxylase Domain-Containing Protein (PHD) Inhibitors for The Treatment of Anemia.
    BindingDB · 2025 · UC San Diego
  79. A BRAF-focused computational pipeline integrating GPT-based molecular generation, hybrid-reward reinforcement learning and retrosynthetic prioritization
    Nikoletta-Maria Koutroumpa, Konstantinos D. Papavasileiou, Haralambos Tzoupis, Charis Georgiou, Alexios N. Matralis, Georgia Melagraki, Antreas Afantitis · 2026 · Artificial Intelligence Chemistry